Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Ayrignac

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2014
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosisElodie Nerrant, Céline Salsac, Mahmoud Charif, et al.
Multiple Sclerosis and Related Disorders|July 25, 2024
Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-upXavier Ayrignac, Safa Aouinti, Thierry Vincent, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|June 10, 2015
Quantitative susceptibility mapping in superficial hemosiderosis of the central nervous systemCyril Dargazanli, Jérémy Deverdun, Caroline Lionnet, et al.
Journal of Neurointerventional Surgery|October 29, 2017
Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation strokeIsabelle Mourand, Eitan Abergel, Daniel Mantilla, et al.
European Radiology|October 14, 2017
Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?Aude Metzger, Emmanuelle Le Bars, Jeremy Deverdun, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2018
Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI FeaturesDimitri Renard, Lavinia Tatu, Laurent Collombier, et al.
European Stroke Journal|November 24, 2023
Diffusion-weighted magnetic resonance imaging in early central retinal artery occlusionKristin Sophie Lange, Isabelle Mourand, Arthur Coget, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related InflammationDimitri Renard, Anne Wacongne, Xavier Ayrignac, et al.
Multiple Sclerosis and Related Disorders|December 29, 2018
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive casesPekes Codjia, Xavier Ayrignac, Clarisse Carra-Dalliere, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2026
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examinationMikael Cohen, Lydiane Mondot, Xavier Ayrignac, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2014
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosisElodie Nerrant, Céline Salsac, Mahmoud Charif, et al.
Multiple Sclerosis and Related Disorders|July 25, 2024
Serum NfL and GFAP are weak predictors of long-term multiple sclerosis prognosis: A 6-year follow-upXavier Ayrignac, Safa Aouinti, Thierry Vincent, et al.
Journal of Neuroradiology = Journal De Neuroradiologie|June 10, 2015
Quantitative susceptibility mapping in superficial hemosiderosis of the central nervous systemCyril Dargazanli, Jérémy Deverdun, Caroline Lionnet, et al.
Journal of Neurointerventional Surgery|October 29, 2017
Favorable revascularization therapy in patients with ASPECTS ≤ 5 on DWI in anterior circulation strokeIsabelle Mourand, Eitan Abergel, Daniel Mantilla, et al.
European Radiology|October 14, 2017
Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?Aude Metzger, Emmanuelle Le Bars, Jeremy Deverdun, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2018
Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI FeaturesDimitri Renard, Lavinia Tatu, Laurent Collombier, et al.
European Stroke Journal|November 24, 2023
Diffusion-weighted magnetic resonance imaging in early central retinal artery occlusionKristin Sophie Lange, Isabelle Mourand, Arthur Coget, et al.
Journal of Alzheimer'S Disease : JAD|January 13, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related InflammationDimitri Renard, Anne Wacongne, Xavier Ayrignac, et al.
Multiple Sclerosis and Related Disorders|December 29, 2018
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive casesPekes Codjia, Xavier Ayrignac, Clarisse Carra-Dalliere, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 22, 2026
Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examinationMikael Cohen, Lydiane Mondot, Xavier Ayrignac, et al.
Pageof 14